Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 24/06 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 24/06 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 626.65Cr 544.75Cr 507.04Cr 465.53Cr 879.11Cr 60TCr 892.73Cr 5.98TCr 2.35TCr 30TCr 2.35TCr 2.3TCr 1LCr | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 609.03Cr 529.43Cr 492.79Cr 452.44Cr 854.39Cr 58TCr 867.63Cr 5.81TCr 2.28TCr 29TCr 2.29TCr 2.24TCr 97TCr | EV / Sales 2024 |
-
| EV / Sales 2025 | 23,18,10,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +2.74% | ||
| 6 months | +64.84% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -1,99,63,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 02/02/26 | Free | Chief Financial Officer | 2,26,000 | 0.1691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +135.88% | +412.66% | 626.65Cr | |
| -1.40% | +2.59% | -1.71% | +11.28% | 4.85TCr | |
| -2.41% | -0.90% | +403.17% | +614.40% | 3.99TCr | |
| -1.16% | +12.96% | +26.45% | +5.03% | 3.87TCr | |
| -1.88% | -3.03% | +4.94% | +47.52% | 3.51TCr | |
| -1.74% | +5.12% | +9.58% | +46.02% | 2.98TCr | |
| -2.85% | -3.92% | - | - | 1.61TCr | |
| -0.21% | -4.04% | +35.09% | +127.95% | 1.61TCr | |
| -0.64% | +2.65% | +1.25% | +8.92% | 1.36TCr | |
| -1.19% | -1.32% | -3.32% | -34.94% | 1.26TCr | |
| Average | -1.27% | +1.14% | +67.92% | +137.65% | 2.57TCr | |
| Weighted average by Cap. | -1.54% | +2.03% | +78.40% | +135.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.04 12.14 11.14 21.04 1.43T 21.37 143.06 56.15 712.87 56.33 55.1 2.39T |
| Net income | -24Cr -20Cr -19Cr -18Cr -33Cr -2.25TCr -34Cr -224.85Cr -88Cr -1.12TCr -89Cr -87Cr -3.76TCr | -20Cr -17Cr -16Cr -15Cr -28Cr -1.89TCr -28Cr -188.4Cr -74Cr -938.76Cr -74Cr -73Cr -3.15TCr |
| Net Debt | -36Cr -32Cr -29Cr -27Cr -51Cr -3.48TCr -52Cr -347.5Cr -136.38Cr -1.73TCr -136.83Cr -133.83Cr -5.81TCr | -18Cr -15Cr -14Cr -13Cr -25Cr -1.68TCr -25Cr -168.05Cr -66Cr -837.38Cr -66Cr -65Cr -2.81TCr |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
